U.S. FDA approves BioDelivery's drug for opioid dependence

[riky]

U.S. FDA approves BioDelivery's drug for opioid dependence

(Reuters) - BioDelivery Sciences International Inc said it had received U.S. regulatory approval for its drug, Bunavail, to treat opioid dependence. The company's shares rose 8.5 percent to $10.85 in extended trading on Friday. BioDelivery said it expects to launch the drug late in the third quarter ending Sept. 30. Opioid dependence affects more than 2 million people in the United States. (Reporting by Shailesh Kuber in Bangalore; Editing by Maju Samuel)

Source: You are not allowed to view links. Register or Login